> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Exemption for Glucose Test System
- URL: https://www.fdaweb.com/comments-sought-on-exemption-for-glucose-test-system/
- Published: 2016-05-04T12:00:00.000Z
- Updated: 2026-09-14T20:59:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135573

*Federal Register* Notice: FDA has received a petition requesting exemption from the premarket notification requirements for a method, metallic reduction, glucose (urinary, non-quantitative) test system in a reagent tablet format that is intended to measure glucosuria (glucose in urine). Such tests systems are used in diagnosing and treating carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia. FDA is publishing this notice to obtain comments by 6/3\. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-05-04/pdf/2016-10388.pdf?ref=fdaweb.com).